{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T15:40:04Z","timestamp":1774712404621,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.vaccine.2008.12.019","type":"journal-article","created":{"date-parts":[[2009,1,8]],"date-time":"2009-01-08T10:56:22Z","timestamp":1231412182000},"page":"1174-1183","source":"Crossref","is-referenced-by-count":57,"title":["A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1)"],"prefix":"10.1016","volume":"27","author":[{"given":"Nazeer H.","family":"Kalhoro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jutta","family":"Veits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silke","family":"Rautenschlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gert","family":"Zimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.12.019_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/978-3-540-70962-6_4","article-title":"Influenza viruses in animal wildlife populations","volume":"315","author":"Webby","year":"2007","journal-title":"Curr Top Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.12.019_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3201\/eid1201.051024","article-title":"H5N1 outbreaks and enzootic influenza","volume":"12","author":"Webster","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2008.12.019_bib3","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3201\/eid1206.051336","article-title":"Host range restriction and pathogenicity in the context of influenza pandemic","volume":"12","author":"Neumann","year":"2006","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2008.12.019_bib4","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1128\/JVI.68.5.3120-3128.1994","article-title":"Reverse genetics provides direct evidence for a correlation of hemagglutinin cleavability and virulence of an avian influenza A virus","volume":"68","author":"Horimoto","year":"1994","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.12.019_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/viro.1999.9716","article-title":"Role of hemagglutinin cleavage for the pathogenicity of influenza virus","volume":"258","author":"Steinhauer","year":"1999","journal-title":"Virology"},{"issue":"9622","key":"10.1016\/j.vaccine.2008.12.019_bib6","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1016\/S0140-6736(08)60627-3","article-title":"Human infection with highly pathogenic H5N1 influenza virus","volume":"371","author":"Gambotto","year":"2008","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.vaccine.2008.12.019_bib7","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1073\/pnas.0308352100","article-title":"Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome","volume":"101","author":"Fouchier","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"issue":"15","key":"10.1016\/j.vaccine.2008.12.019_bib8","doi-asserted-by":"crossref","first-page":"8372","DOI":"10.1128\/JVI.78.15.8372-8381.2004","article-title":"Effect of vaccine use in the evolution of Mexican lineage H5N2 avian influenza virus","volume":"78","author":"Lee","year":"2004","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.019_bib9","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2307\/1591189","article-title":"Protection of chickens against highly pathogenic avian influenza virus (H5N2) by recombinant fowlpox viruses","volume":"35","author":"Beard","year":"1991","journal-title":"Avian Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2008.12.019_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0264-410X(91)90055-B","article-title":"Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens","volume":"9","author":"Webster","year":"1991","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.019_bib11","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2307\/1592246","article-title":"Immunity to Mexican H5N2 avian influenza viruses induced by a fowl pox-H5 recombinant","volume":"40","author":"Webster","year":"1996","journal-title":"Avian Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2008.12.019_bib12","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/0264-410X(88)90101-6","article-title":"Protective immunity against avian influenza induced by a fowlpox virus recombinant","volume":"6","author":"Taylor","year":"1988","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2008.12.019_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-1135(00)00176-0","article-title":"Vaccines protect chickens against H5 highly pathogenic avian influenza in the face of genetic changes in field viruses over multiple years","volume":"74","author":"Swayne","year":"2000","journal-title":"Vet Microbiol"},{"issue":"30","key":"10.1016\/j.vaccine.2008.12.019_bib14","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1016\/S0264-410X(01)00167-0","article-title":"Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene","volume":"19","author":"Luschow","year":"2001","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2008.12.019_bib15","doi-asserted-by":"crossref","first-page":"8203","DOI":"10.1073\/pnas.0602566103","article-title":"Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease","volume":"103","author":"Park","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"10.1016\/j.vaccine.2008.12.019_bib16","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.1073\/pnas.0602461103","article-title":"Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza","volume":"103","author":"Veits","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2008.12.019_bib17","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/JVI.01514-06","article-title":"Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses","volume":"81","author":"Ge","year":"2007","journal-title":"J Virol"},{"issue":"21","key":"10.1016\/j.vaccine.2008.12.019_bib18","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1016\/j.vaccine.2008.02.056","article-title":"Protection of chickens against avian influenza with non-replicating adenovirus-vectored vaccine","volume":"26","author":"Toro","year":"2008","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2008.12.019_bib19","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1016\/j.vaccine.2006.09.047","article-title":"Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector","volume":"25","author":"Toro","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2008.12.019_bib20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.virol.2007.04.021","article-title":"Vesicular stomatitis virus vectors expressing avian influenza H5 HA induce cross-neutralizing antibodies and long-term protection","volume":"366","author":"Schwartz","year":"2007","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.vaccine.2008.12.019_bib21","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.1128\/JVI.72.6.4704-4711.1998","article-title":"Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge","volume":"72","author":"Roberts","year":"1998","journal-title":"J Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.12.019_bib22","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1128\/JVI.73.5.3723-3732.1999","article-title":"Attenuated vesicular stomatitis viruses as vaccine vectors","volume":"73","author":"Roberts","year":"1999","journal-title":"J Virol"},{"issue":"Pt 5","key":"10.1016\/j.vaccine.2008.12.019_bib23","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1099\/vir.0.80788-0","article-title":"Use of influenza C virus glycoprotein HEF for generation of vesicular stomatitis virus pseudotypes","volume":"86","author":"Hanika","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2008.12.019_bib24","doi-asserted-by":"crossref","unstructured":"Hierholzer JC, Killington RA. Virus isolation and quantitation, p. 36\u20138. In Mahy BW, Kangro HO (Eds.), Virology methods manual. London, United Kingdom: Academic Press Limited; 1996.","DOI":"10.1016\/B978-012465330-6\/50003-8"},{"issue":"1","key":"10.1016\/j.vaccine.2008.12.019_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0014-5793(95)00843-X","article-title":"Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase","volume":"371","author":"Sutter","year":"1995","journal-title":"FEBS Lett"},{"issue":"10","key":"10.1016\/j.vaccine.2008.12.019_bib26","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1073\/pnas.92.10.4477","article-title":"Recombinant vesicular stomatitis viruses from DNA","volume":"92","author":"Lawson","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.vaccine.2008.12.019_bib27","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1128\/JVI.70.4.2318-2323.1996","article-title":"The minimal conserved transcription stop\u2013start signal promotes stable expression of a foreign gene in vesicular stomatitis virus","volume":"70","author":"Schnell","year":"1996","journal-title":"J Virol"},{"issue":"6296","key":"10.1016\/j.vaccine.2008.12.019_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/348091a0","article-title":"Product review. New mammalian expression vectors","volume":"348","author":"Moss","year":"1990","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.vaccine.2008.12.019_bib29","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.vaccine.2008.01.016","article-title":"Protective efficacy of several vaccines against highly pathogenic H5N1 avian influenza virus under experimental conditions","volume":"26","author":"Veits","year":"2008","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2008.12.019_bib30","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1128\/JCM.40.9.3256-3260.2002","article-title":"Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes","volume":"40","author":"Spackman","year":"2002","journal-title":"J Clin Microbiol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2008.12.019_bib31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jviromet.2005.05.030","article-title":"Validation of a real-time RT-PCR assay for sensitive and specific detection of classical swine fever","volume":"130","author":"Hoffmann","year":"2005","journal-title":"J Virol Methods"},{"issue":"8","key":"10.1016\/j.vaccine.2008.12.019_bib32","doi-asserted-by":"crossref","first-page":"5982","DOI":"10.1128\/JVI.71.8.5982-5989.1997","article-title":"High-efficiency incorporation of functional influenza virus glycoproteins into recombinant vesicular stomatitis viruses","volume":"71","author":"Kretzschmar","year":"1997","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.12.019_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/viro.1995.1455","article-title":"Neuraminidase is essential for fowl plague virus hemagglutinin to show hemagglutinating activity","volume":"212","author":"Ohuchi","year":"1995","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.019_bib34","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1128\/JVI.68.2.911-919.1994","article-title":"Influenza virus M2 protein ion channel activity stabilizes the native form of fowl plague virus hemagglutinin during intracellular transport","volume":"68","author":"Takeuchi","year":"1994","journal-title":"J Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2008.12.019_bib35","doi-asserted-by":"crossref","first-page":"6271","DOI":"10.1128\/JVI.78.12.6271-6281.2004","article-title":"RNA recombination in vivo in the absence of viral replication","volume":"78","author":"Gallei","year":"2004","journal-title":"J Virol"},{"issue":"22","key":"10.1016\/j.vaccine.2008.12.019_bib36","doi-asserted-by":"crossref","first-page":"14261","DOI":"10.1128\/JVI.79.22.14261-14270.2005","article-title":"Noncytopathogenic pestivirus strains generated by nonhomologous RNA recombination: alterations in the NS4A\/NS4B coding region","volume":"79","author":"Gallei","year":"2005","journal-title":"J Virol"},{"issue":"20","key":"10.1016\/j.vaccine.2008.12.019_bib37","doi-asserted-by":"crossref","first-page":"11201","DOI":"10.1128\/JVI.77.20.11201-11211.2003","article-title":"Genetic recombination during coinfection of two mutants of human respiratory syncytial virus","volume":"77","author":"Spann","year":"2003","journal-title":"J Virol"},{"issue":"19","key":"10.1016\/j.vaccine.2008.12.019_bib38","doi-asserted-by":"crossref","first-page":"9805","DOI":"10.1128\/JVI.01336-08","article-title":"What are the risks \u2013 hypothetical and observed \u2013 of recombination involving live vaccines and vaccine vectors based on nonsegmented negative-strain RNA viruses?","volume":"82","author":"Collins","year":"2008","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.12.019_bib39","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1128\/MMBR.64.4.709-724.2000","article-title":"Cytopathogenesis and inhibition of host gene expression by RNA viruses","volume":"64","author":"Lyles","year":"2000","journal-title":"Microbiol Mol Biol Rev"},{"issue":"29\u201330","key":"10.1016\/j.vaccine.2008.12.019_bib40","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1016\/j.vaccine.2008.04.069","article-title":"Enhancement of immunostimulatory properties of exosomal vaccines by incorporation of fusion-competent G protein of vesicular stomatitis virus","volume":"26","author":"Temchura","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.019_bib41","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.virol.2006.12.032","article-title":"Vesicular stomatitis virus glycoprotein G activates a specific antiviral Toll-like receptor 4-dependent pathway","volume":"362","author":"Georgel","year":"2007","journal-title":"Virology"},{"issue":"Pt 5","key":"10.1016\/j.vaccine.2008.12.019_bib42","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1099\/0022-1317-71-5-1169","article-title":"Characterization and immunological properties of influenza A virus nucleoprotein (NP): cell-associated NP isolated from infected cells or viral NP expressed by vaccinia recombinant virus do not confer protection","volume":"71","author":"Stitz","year":"1990","journal-title":"J Gen Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.12.019_bib43","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2307\/1591743","article-title":"Assessment of retrovirus-expressed nucleoprotein as a vaccine against lethal influenza virus infections of chickens","volume":"36","author":"Brown","year":"1992","journal-title":"Avian Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2008.12.019_bib44","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.copbio.2007.11.002","article-title":"Influenza virus-specific cytotoxic T lymphocytes: a correlate of protection and a basis for vaccine development","volume":"18","author":"Rimmelzwaan","year":"2007","journal-title":"Curr Opin Biotechnol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.12.019_bib45","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4161\/hv.4.2.5169","article-title":"A call to cellular & humoral arms: enlisting cognate T cell help to develop broad-spectrum vaccines against influenza A","volume":"4","author":"McMurry","year":"2008","journal-title":"Hum Vaccin"},{"issue":"21","key":"10.1016\/j.vaccine.2008.12.019_bib46","doi-asserted-by":"crossref","first-page":"13231","DOI":"10.1128\/JVI.79.21.13231-13238.2005","article-title":"A single-cycle vaccine vector based on vesicular stomatitis virus can induce immune responses comparable to those generated by a replication-competent vector","volume":"79","author":"Publicover","year":"2005","journal-title":"J Virol"},{"issue":"18","key":"10.1016\/j.vaccine.2008.12.019_bib47","doi-asserted-by":"crossref","first-page":"9273","DOI":"10.1128\/JVI.00915-08","article-title":"Immune response in the absence of neurovirulence in mice infected with m protein mutant vesicular stomatitis virus","volume":"82","author":"Ahmed","year":"2008","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2008.12.019_bib48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0092-8674(84)90527-0","article-title":"Vesicular stomatitis virus infects and matures only through the basolateral surface of the polarized epithelial cell line, MDCK","volume":"38","author":"Fuller","year":"1984","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.vaccine.2008.12.019_bib49","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1128\/JVI.76.8.4103-4107.2002","article-title":"Vesicular stomatitis virus glycoprotein does not determine the site of virus release in polarized epithelial cells","volume":"76","author":"Zimmer","year":"2002","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.vaccine.2008.12.019_bib50","doi-asserted-by":"crossref","first-page":"9317","DOI":"10.1128\/JVI.78.17.9317-9324.2004","article-title":"Characterization of nonpathogenic, live, viral vaccine vectors inducing potent cellular immune responses","volume":"78","author":"Publicover","year":"2004","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.12.019_bib51","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1128\/JVI.02525-06","article-title":"Replication and propagation of attenuated vesicular stomatitis virus vectors in vivo: vector spread correlates with induction of immune responses and persistence of genomic RNA","volume":"81","author":"Simon","year":"2007","journal-title":"J Virol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08017519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08017519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T13:00:35Z","timestamp":1589461235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08017519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0264410X08017519"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.12.019","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}